Acadia Pharmaceuticals (ACAD) Inventory (2016 - 2026)
Acadia Pharmaceuticals (ACAD) posted quarterly Inventory of $31.6 million for Q1 2026, up 37.59% year-over-year from $22.9 million in Q1 2025, and down 8.93% quarter-over-quarter from $34.7 million in Q4 2025.
Acadia Pharmaceuticals (ACAD) Inventory (2016 - 2026) Analysis & Trends
Acadia Pharmaceuticals' Inventory history runs 11 years deep, the most recent figure standing at $31.6 million for Q1 2026.
- In Q1 2026, Inventory rose 37.59% year-over-year to $31.6 million; the TTM figure through Mar 2026 stood at $31.6 million (up 37.59% YoY), while the FY2025 annual figure was $34.7 million, up 57.96% from the prior year.
- Inventory for Q1 2026 stood at $31.6 million, down from $34.7 million in the prior quarter.
- The five-year high for Inventory was $71.5 million in Q2 2024, with the low at $5.8 million in Q3 2022.
- The 5-year median for Inventory is $22.9 million (2025), against an average of $27.0 million.
- The sharpest annual moves came in 2024 and 2025: Inventory surged 916.18% in 2024, then slumped 63.48% in 2025.
- Acadia Pharmaceuticals' Inventory stood at $6.6 million in 2022, then soared by 439.77% to $35.8 million in 2023, then slumped by 38.72% to $21.9 million in 2024, then surged by 57.96% to $34.7 million in 2025, then decreased by 8.93% to $31.6 million in 2026.
- Business Quant data shows ACAD's Inventory at $31.6 million in Q1 2026, $34.7 million in Q4 2025, and $29.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 371.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 732.60 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 358,916.96 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 97.11 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Acadia Pharmaceuticals | 4.86 Bn | 3.90 Bn | 279.64 Mn | 32.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.37 Mn |
| Mar 31, 2026 | 31.57 Mn |
| Dec 31, 2025 | 34.67 Mn |
| Sep 30, 2025 | 29.10 Mn |
| Jun 30, 2025 | 26.12 Mn |
| Mar 31, 2025 | 22.95 Mn |
| Dec 31, 2024 | 21.95 Mn |
| Sep 30, 2024 | 61.04 Mn |
| Jun 30, 2024 | 71.53 Mn |
| Mar 31, 2024 | 61.94 Mn |
| Dec 31, 2023 | 35.82 Mn |
| Sep 30, 2023 | 20.77 Mn |
| Jun 30, 2023 | 9.20 Mn |
| Mar 31, 2023 | 6.10 Mn |
| Dec 31, 2022 | 6.64 Mn |
| Sep 30, 2022 | 5.84 Mn |
| Jun 30, 2022 | 6.33 Mn |
| Mar 31, 2022 | 7.01 Mn |
| Dec 31, 2021 | 7.88 Mn |
| Sep 30, 2021 | 14.34 Mn |